You are here

Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA #sort ascending PI/Project Leader Institution Title Status
2020 R43 CA236167 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2019 R43 CA236167 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations NCE
2019 R43 CA236177 PAR-18-303 KASOJI, SANDEEP TRIANGLE BIOTECHNOLOGY, INC. SBIR: Technology for Overcoming Bottlenecks in Chromatin Extraction from Challenging Biological Samples Complete
2020 R44 CA250672 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Active
2019 R43 CA239967 PAR-18-303 BROWN, MARK T CLAREMONT BIOSOLUTIONS, LLC Rapid sample preparation method for high molecular weight DNA from tumor tissues suitable for structural variant analysis Complete
2015 R43 CA187787 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete
2015 R43 CA192674 PAR-13-327 LELENTAL, MARK CATASSAYS NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION Complete
2015 R43 CA193087 PAR-13-327 MANDECKI, WLODEK PHARMASEQ, INC. SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT Complete
2015 R43 CA193096 PAR-13-327 JIANG, LI A'AS, INC. KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA Complete
2015 R43 CA193101 PAR-13-327 TRAN, HIEP T ABZYME THERAPEUTICS, LLC HYBRIDOMA FREE MULTIPLEX APPROACH FOR ACCELERATING MOUSE MONOCLONAL ANTIBODY GENERATION Complete
2015 R43 CA193128 PAR-13-327 MESSMER, BRADLEY T ABREOS BIOSCIENCES, INC. MULTIPLEXED DENANO PROTEIN ASSAY AND QUANTITATION: SEQUENCING BASED PROTEOMICS Complete
2015 R43 CA193134 PAR-13-327 NEVO, EREZ ROBIN MEDICAL, INC. COMBINED OPTICAL AND MR MICROSCOPY SYSTEM FOR THIN TISSUE HISTOPATHOLOGY ANALYSIS Complete
2015 R43 CA199055 PAR-13-327 MCCONNELL, TIMOTHY S ISOPLEXIS, INC. A SINGLE CELL MULTI-PROTEIN DEVICE TO FACILITATE CANCER IMMUNOTHERAPY Complete
2015 R43 CA199058 PAR-13-327 SARAF, RAVI VAJRA INSTRUMENTS, INC. PROFILING CIRCULATING MIRNA WITHOUT PCR FOR EARLY DETECTION OF PANCREATIC CANCER Complete
2016 R43 CA203671 PAR-13-327 OUELLETTE, STEVEN BRADLEY KINASENSE, LLC DEVELOPMENT OF AN ASSAY PLATFORM FOR MEASURING ENDOGENOUS KINASE ACTIVITY Complete
2015 R43 CA199142 PAR-13-327 ORBAI, LUCIAN CELL DATA SCIENCES, INC. RESCUING NUCLEIC ACIDS FROM FORMALIN DAMAGE IN CANCER SPECIMENS Complete
2016 R43 CA203675 PAR-13-327 KLUGE, JONATHAN AUGUST VAXESS TECHNOLOGIES, INC. SILK-BASED BLOOD SAMPLE STABILIZATION FOR PROSTATE CANCER DIAGNOSTICS Complete
2015 R43 CA199152 PAR-13-327 EASTBURN, DENNIS J MISSION BIO, INC. MOLECULAR CHARACTERIZATION OF CIRCULATING TUMOR CELLS WITH PCR-ACTIVATED CELL SORTING Complete
2016 R43 CA203629 PAR-13-327 GUNDERSON, KEVIN L ENCODIA, INC. Development of Reagents for Sequencing Proteins and Protein Fragments on a Next-Generation DNA Sequencer Complete
2015 R43 CA199211 PAR-13-327 GAU, VINCENT JEN-JR GENEFLUIDICS, INC. PROMOTE HPV SCREENING RATE WITH A NON-INVASIVE HPV POC CARTRIDGE Complete
2016 R43 CA203647 PAR-13-327 LIM, MARK AMBERGEN, INC Photocleavage Technology for Improved Serum-based Multi-Biomarker Cancer Assays Complete
2016 R43 CA203681 PAR-13-327 KING, JEFFREY S VIROGENOMICS BIODEVELOPMENT, INC. Sensitive Single Cell PhosphoCount Platform for Drug-Insensitive Cell Detection and Combination Drug Screening for Leukemia Complete
2016 R44 CA199194 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2016 R44 CA187852 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete
2014 R43 CA187852 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. B CELL REPERTOIRE MOLECULAR PLATFORM FOR ANTIBODY DRUG DISCOVERY Complete
2014 R43 CA188154 PAR-13-327 FELLMANN, CHRISTOF MIRIMUS, INC. RNA INTERFERENCE - GENETICALLY ENGINEERED MOUSE MODELS(RNAI-GEMMS): A NOVEL APPRO Complete
2014 R44 CA161965 PAR-13-327 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2017 R43 CA214386 PAR-13-327 PEYTAVI, REGIS BLUENOVO BIOSYSTEMS, INC. Detection of Methylation and Translocation Events by Novel Sequencing Technology Complete
2017 R44 CA188154 PAR-13-327 PREMSRIRUT, PREM KHOVABUTR MIRIMUS, INC. Next generation CRISPR/Cas9-RNAi mouse models for accelerated drug discovery research Complete
2002 R21 CA092739 PAR-01-106 BAKER, LAURENCE HOWARD UNIVERSITY OF MICHIGAN AT ANN ARBOR MOLECULAR DIAGNOSIS OF SARCOMAS Complete
2004 R21 CA107858 PAR-01-106 MAITRA, ANIRBAN JOHNS HOPKINS UNIVERSITY A SEQUENCING MICROARRAY FOR MITOCHONDRIAL MUTATIONS Complete
2002 R21 CA094365 PAR-01-106 KENAN, DANIEL J. DUKE UNIVERSITY ENDOTHELIAL CELL MOLECULAR ALTERATIONS IN CANCER Complete
2004 R21 CA107932 PAR-01-106 DE VERE WHITE, RALPH W. UNIVERSITY OF CALIFORNIA DAVIS YEAST ASSAY FOR P53 MOLECULAR ANALYSIS IN BLADDER CANCER Complete
2003 R21 CA099191 PAR-01-106 LABAER, JOSHUA HARVARD UNIVERSITY (MEDICAL SCHOOL) FUNCTIONAL PROTEOMICS OF BREAST CANCER Complete
2002 R21 CA094392 PAR-01-106 CHUONG, CHENG-MING UNIVERSITY OF SOUTHERN CALIFORNIA HIGH RESOLUTION MICROARRAY ANALYSIS OF CANCER Complete
2004 R21 CA105514 PAR-01-106 SIMS, CHRISTOPHER E UNIVERSITY OF CALIFORNIA IRVINE ASSAYING TYROSINE KINASE ACTIVITY: A NEW PARADIGM Complete
2003 R21 CA101150 PAR-01-106 ANGELETTI, RUTH HOGUE YESHIVA UNIVERSITY PROTEOMICS OF HEPATIC CARCINOGENESIS Complete
2002 R21 CA097511 PAR-01-106 LEVENSON, VICTOR V NORTHWESTERN UNIVERSITY DNA METHYLATION IN PATIENTS WITH NON-HODGKIN'S LYMPHOMA Complete
2004 R21 CA103548 PAR-01-106 JAY, DANIEL G. TUFTS UNIVERSITY BOSTON PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS Complete
2003 R21 CA099835 PAR-01-106 WOODS, VIRGIL L UNIVERSITY OF CALIFORNIA SAN DIEGO ENHANCED CRYSTALLOGRAPHY OF CANCER-IMPLICATED PROTEINS Complete
2002 R21 CA092731 PAR-01-106 SESHI, BEERELLI LA BIOMED RES INST/ HARBOR UCLA MED CTR FUNCTIONAL PROTEOMICS OF LEUKEMIC MARROW STROMAL CELLS Complete
2004 R21 CA101171 PAR-01-106 DOVICHI, NORMAN J UNIVERSITY OF WASHINGTON SINGLE CELL PROTEIN FINGERPRINTING - BARRETT'S ESOPHAGUS Complete
2003 R21 CA092752 PAR-01-106 BARRON, ANNELISE EMILY NORTHWESTERN UNIVERSITY FAST MUTATION DETECTION BY TANDEM SSCP/HA ON MICROCHIPS Complete
2004 R21 CA107966 PAR-01-106 SCHROEDER, JANE CLOWNEY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL EPIDEMIOLOGY OF ATYPICAL EPSTEIN-BARR VIRUS IN LYMPHOMA Complete
2003 R21 CA099246 PAR-01-106 SOPER, STEVEN ALLAN LOUISIANA STATE UNIV A&M COL BATON ROUGE MICROSAMPLING UNIT FOR CAPTURING LOW ABUNDANT CELLS Complete
2004 R33 CA105405 PAR-01-106 VIDAL, MARC DANA-FARBER CANCER INSTITUTE INTEGRATED INTERACTOME MAPPING Complete
2004 R33 CA097526 PAR-01-106 ZANGAR, RICHARD C BATTELLE PACIFIC NORTHWEST LABORATORIES PROTEOMIC IDENTIFICATION OF NAF BIOMARKERS Complete
2004 R33 CA083208 PAR-01-106 SINGER, ROBERT H ALBERT EINSTEIN COL OF MED YESHIVA UNIV FISH AND CHIPS: SINGLE CELL EXPRESSION OF CANCER GENES Complete
2003 R33 CA101136 PAR-01-106 FURGE, KYLE A VAN ANDEL RESEARCH INSTITUTE COMPARATIVE GENOMIC ANALYSIS OF MICROARRAY DATA Complete
2003 R33 CA103068 PAR-01-106 COLLINS, COLIN C UNIVERSITY OF CALIFORNIA SAN FRANCISCO DEVELOPMENT OF ESP: STRUCTURAL & FUNCTIONAL ONCOGENOMICS Complete

Pages



National Cancer Institute at the National Institutes of Health

 

NIH… Turning Discovery Into Health®